Methylprednisolone Sodium Succinate Injection, Powder, For Solution
Product Images NDC 0143-9753

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 0143-9753). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methylprednisolone Structure (Methylprednisolone Sodium Succinate For Injection 1)

Chemical structure of methylprednisolone sodium succinate, showing the steroid backbone and succinate ester side chain with sodium salt.*

FDA Label Image

Methylprednisolone Sodium Succinate For Injection Usp 40 mg Vial (Methylprednisolone Sodium Succinate For Injection 2)

Label for Methylprednisolone Sodium Succinate injection, USP, 40 mg per vial single-dose powder for solution. The label indicates use for intramuscular or intravenous administration and directs reconstitution with Sterile Water or Bacteriostatic Water. It is manufactured by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Methylprednisolone Sodium Succinate For Injection Usp 40 mg Carton (Methylprednisolone Sodium Succinate For Injection 3)

Methylprednisolone Sodium Succinate for Injection, USP 40 mg per vial powder label. The label indicates use for intramuscular or intravenous injection, with instructions to reconstitute with 1 mL water for injection or bacteriostatic water. Contains 25 single-dose vials. The label notes storage conditions, usage instructions, and that the product is distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Methylprednisolone Sodium Succinate For Injection Usp 125 mg Vial (Methylprednisolone Sodium Succinate For Injection 4)

Packaging label for Methylprednisolone Sodium Succinate Injection, USP, 125 mg per vial. The label indicates it is a powder for solution for injection, intended for intramuscular or intravenous use only. The product is a single-dose vial distributed by Hikma Pharmaceuticals USA Inc., with instructions to reconstitute with water for injection or benzyl alcohol prior to use.*

FDA Label Image

Methylprednisolone Sodium Succinate For Injection Usp 125 mg Carton (Methylprednisolone Sodium Succinate For Injection 5)

Label for Methylprednisolone Sodium Succinate injection, USP 125 mg per vial, powder for solution. The label indicates it is for intramuscular or intravenous use only and contains 25 single-dose vials. Labeler is Hikma Pharmaceuticals USA Inc. Instructions for reconstitution with sterile water or bacteriostatic water and storage conditions are printed on the label.*

FDA Label Image

Representative Serialization Image (Methylprednisolone Sodium Succinate For Injection 6)

A medication label containing a GTIN barcode and human-readable identifiers, including SN (serial number), EXP (expiration date), and LOT (lot number) fields. Text is black on a white background, formatted for tracking and identification purposes. No brand, strength, or dosage form is visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.